• Home

  • Documents

  • kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical...
23

kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia

  • Upload
    ngobao

  • View
    217

  • Download
    0

Embed Size (px)

Citation preview

Page 1: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 2: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 3: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 4: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 5: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 6: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 7: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 8: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 9: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 10: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 11: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 12: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 13: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 14: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 15: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 16: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 17: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 18: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 19: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 20: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 21: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 22: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia
Page 23: kouseikyoku.mhlw.go.jp · Repetitive element—polymerase chain reaction for genotyping of clinical and environmental isolates of ... Improvement in antipsychotic—induced hyperprolactinemia

Does hyperprolactinemia affect hepatic regeneration

Does hyperprolactinemia affect hepatic regeneration

Documents
Case Report Hyperprolactinemia Secondary to Allergic

Case Report Hyperprolactinemia Secondary to Allergic

Documents
Chronic hyperprolactinemia evoked by disruption of

Chronic hyperprolactinemia evoked by disruption of

Documents
ANTIPSYCHOTIC 2003

ANTIPSYCHOTIC 2003

Documents
Guidelines for Antipsychotic-Induced Hyperprolactinemia26... · Guidelines for Antipsychotic-Induced Hyperprolactinemia Brigitta E. Miyamoto; Martha Galecki, MD; and Dimitry Francois,

Guidelines for Antipsychotic-Induced Hyperprolactinemia26... · Guidelines for Antipsychotic-Induced Hyperprolactinemia Brigitta E. Miyamoto; Martha Galecki, MD; and Dimitry Francois,

Documents
Hyperprolactinemia - CORE

Hyperprolactinemia - CORE

Documents
Diagnosis Treatment of Hyperprolactinemia

Diagnosis Treatment of Hyperprolactinemia

Documents
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine … · 2021. 1. 15. · Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine … · 2021. 1. 15. · Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline

Documents
From Antipsychotic-related Hyperprolactinemia to

From Antipsychotic-related Hyperprolactinemia to

Documents
Hyperprolactinemia in Patients on Antipsychotic Drugs ...psychrights.org/research/Digest/NLPs/BloodClots/...Therefore, hyperprolactinemia might be the yet unknown acquired risk factor

Hyperprolactinemia in Patients on Antipsychotic Drugs ...psychrights.org/research/Digest/NLPs/BloodClots/...Therefore, hyperprolactinemia might be the yet unknown acquired risk factor

Documents
Hyperprolactinemia & Ovarian Acyclicity in Captive African

Hyperprolactinemia & Ovarian Acyclicity in Captive African

Documents
Pharmacology of Antipsychotic drug Pharmacology of Antipsychotic drugs

Pharmacology of Antipsychotic drug Pharmacology of Antipsychotic drugs

Documents
Antipsychotic Medications

Antipsychotic Medications

Health & Medicine
Antipsychotics and Hyperprolactinemia: Prevalence and … · Antipsychotics and Hyperprolactinemia: Prevalence . and Risk Factors. ... of SSRIs antidepressants or MAO ... and presence

Antipsychotics and Hyperprolactinemia: Prevalence and … · Antipsychotics and Hyperprolactinemia: Prevalence . and Risk Factors. ... of SSRIs antidepressants or MAO ... and presence

Documents
Pituitary Disorders and Hyperprolactinemia 1

Pituitary Disorders and Hyperprolactinemia 1

Documents
PATIENTS WITH HYPERPROLACTINEMIA

PATIENTS WITH HYPERPROLACTINEMIA

Documents
Hyperprolactinemia induced histological and cytoskeletal ......Hyperprolactinemia (HPRL) is the most common endocrine disorder of the hypothalamic-pituitary axis. A prolactinoma is

Hyperprolactinemia induced histological and cytoskeletal ......Hyperprolactinemia (HPRL) is the most common endocrine disorder of the hypothalamic-pituitary axis. A prolactinoma is

Documents
Antipsychotic Drugs

Antipsychotic Drugs

Documents
Antipsychotic medication

Antipsychotic medication

Documents
Antipsychotic Agents

Antipsychotic Agents

Health & Medicine
ANTIPSYCHOTIC DRUGS ANTIPSYCHOTIC DRUGS Anti schizophrenic drugs Neuroleptic drugs Major tranquilizers

ANTIPSYCHOTIC DRUGS ANTIPSYCHOTIC DRUGS Anti schizophrenic drugs Neuroleptic drugs Major tranquilizers

Documents
Antipsychotic Review

Antipsychotic Review

Documents
hyperprolactinemia - WordPress.com

hyperprolactinemia - WordPress.com

Documents
Hyperprolactinemia and Infertility

Hyperprolactinemia and Infertility

Documents
Chlorpromazine-Induced Hyperprolactinemia on Rat’s Uterus · show hyperprolactinemia-induced histological changes. Methods: Albino Wistar rats (n = 32) were divided into four groups

Chlorpromazine-Induced Hyperprolactinemia on Rat’s Uterus · show hyperprolactinemia-induced histological changes. Methods: Albino Wistar rats (n = 32) were divided into four groups

Documents
CORRELATION OF HYPERPROLACTINEMIA WITH …

CORRELATION OF HYPERPROLACTINEMIA WITH …

Documents
Potential roles of Kisspeptin in the hyperprolactinemia

Potential roles of Kisspeptin in the hyperprolactinemia

Documents
Consideration upon Antipsychotic Therapy in Women · can be an element for the background of a comprehensive view of the psychiatry, ... • Antipsychotic-induced Hyperprolactinemia

Consideration upon Antipsychotic Therapy in Women · can be an element for the background of a comprehensive view of the psychiatry, ... • Antipsychotic-induced Hyperprolactinemia

Documents
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine …endosuem.org.uy/wp-content/uploads/2015/05/Gu%edas... · 2015-06-03 · Diagnosis and Treatment of Hyperprolactinemia:

Diagnosis and Treatment of Hyperprolactinemia: An Endocrine …endosuem.org.uy/wp-content/uploads/2015/05/Gu%edas... · 2015-06-03 · Diagnosis and Treatment of Hyperprolactinemia:

Documents
Association between Antipsychotic Treatment and ......Antipsychotic-Induced Hyperlipidemia 1 Association between Antipsychotic Treatment and Hyperlipidemia among California Medicaid

Association between Antipsychotic Treatment and ......Antipsychotic-Induced Hyperlipidemia 1 Association between Antipsychotic Treatment and Hyperlipidemia among California Medicaid

Documents